Jump to content

Category:David Joerg

From WikiTrademarks

David Joerg

Executive Summary

David Joerg is an inventor who has filed 2 patents. Their primary areas of innovation include for simulation or modelling of medical disorders (2 patents), for electronic clinical trials or questionnaires (1 patents), relating to drugs or medications, e.g. for ensuring correct administration to patients (1 patents), and they have worked with companies such as Fresenius Medical Care Holdings, Inc. (2 patents). Their most frequent collaborators include (2 collaborations), (2 collaborations), (2 collaborations).

Patent Filing Activity

File:David Joerg Monthly Patent Applications.png

Technology Areas

File:David Joerg Top Technology Areas.png

List of Technology Areas

  • G16H50/50 (for simulation or modelling of medical disorders): 2 patents
  • G16H10/20 (for electronic clinical trials or questionnaires): 1 patents
  • G16H20/10 (relating to drugs or medications, e.g. for ensuring correct administration to patients): 1 patents
  • G16H20/40 (relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture): 1 patents
  • G16H50/70 (for mining of medical data, e.g. analysing previous cases of other patients): 1 patents
  • G16H50/30 (for calculating health indices; for individual health risk assessment): 1 patents
  • A61M2205/52 (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals): 1 patents
  • A61M2230/205 (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals): 1 patents
  • A61M2230/207 (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals): 1 patents

Companies

File:David Joerg Top Companies.png

List of Companies

  • Fresenius Medical Care Holdings, Inc.: 2 patents

Collaborators

Subcategories

This category has the following 6 subcategories, out of 6 total.

Cookies help us deliver our services. By using our services, you agree to our use of cookies.